Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00057629 · ClinicalTrials.gov registry record · Phase 2

Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault

A Phase 2 study of Stress Disorders, Post-Traumatic, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 2
Development phase
187
Enrollment target
2
Study locations

NCT00057629: Completed Phase 2 study of Stress Disorders, Post-Traumatic, sponsored by University of Pennsylvania.

NCT00057629 is a Phase 2 study of Stress Disorders, Post-Traumatic that has completed, run by University of Pennsylvania. The registered enrollment target is 187 participants, above the 153-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (22% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00057629, a Phase 2 study of Stress Disorders, Post-Traumatic, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 2
Development phase
187 participants
Enrollment target
2
Study locations

Study Summary

This study will evaluate the effectiveness of a brief cognitive behavioral therapy, administered by community agencies, for the treatment of patients with Post Traumatic Stress Disorder (PTSD).

Interventions

  • BEHAVIORAL Prolonged Exposure (PE)
  • BEHAVIORAL Treatment as usual group therapy (TUGT)
  • BEHAVIORAL Supportive counseling (SC)

Study Locations (2)

Pennsylvania

  • Center for the Treatment and Study of Anxiety, University of Pennsylvania - Philadelphia
  • Women Organized Against Rape (WOAR) - Philadelphia

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2002-01
Est. Completion 2009-08
Phase Phase 2
University of Pennsylvania

1,423 total trials

What the finished NCT00057629 record still lists

NCT00057629 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, above the 153-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (22% higher).

The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 3 interventions - of which Prolonged Exposure (PE) is the first listed.

NCT00057629 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00057629 about?

NCT00057629 is a clinical study titled "Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault". This study will evaluate the effectiveness of a brief cognitive behavioral therapy, administered by community agencies, for the treatment of patients with Post Traumatic Stress Disorder (PTSD).

What is the current status of trial NCT00057629?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 187 participants. The study started on 2002-01. Estimated completion is 2009-08.

What conditions does trial NCT00057629 study?

This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.

What interventions are being tested in trial NCT00057629?

The interventions under investigation include: Prolonged Exposure (PE) (BEHAVIORAL), Treatment as usual group therapy (TUGT) (BEHAVIORAL), Supportive counseling (SC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00057629?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00057629 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Disorders, Post-Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00057629's enrollment target sits among peer trials

187 16th of 66 higher than 51 of 66 other Stress Disorders, Post-Traumatic trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06153251 · 187 participants · Phase 1

    A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

  • NCT06254898 · 187 participants · NA

    Use of Incentives for Stressful Medical Procedures

  • NCT07062237 · 187 participants · NA

    A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence

  • NCT07217574 · 187 participants

    Program in Oncology for Tribal Health Systems.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00057629, the US trial registry maintained by the National Library of Medicine. NCT00057629 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.